Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6326
Armata Pharmaceuticals
ARMP
$135M
| – | – |
0
| – | – |
2017 Q2
1 quarter
|
|
6327
Atlanticus Holdings
ATLC
$1.42B
| $0 | ﹤0.01% |
150
| – | – |
2017 Q1
2 quarters
|
|
6328
Atossa Therapeutics
ATOS
$24.3M
| $0 | ﹤0.01% |
+1
| New | +$79 |
2017 Q3
0 quarters
|
|
6329
AMREP Corp
AXR
$110M
| $0 | ﹤0.01% |
27
| – | – |
2016 Q2
5 quarters
|
|
6330
DELISTED
BioLife Solutions
BLFS
| $0 | ﹤0.01% |
31
+16
| +107% | +$66 |
2017 Q2
1 quarter
|
|
6331
Biomerica
BMRA
$8.46M
| – | – |
-492
| Closed | -$10K | – |
|
6332
Barnwell Industries
BRN
$14.1M
| – | – |
-432
| Closed | -$1K | – |
|
6333
BRT Apartments
BRT
$252M
| $0 | ﹤0.01% |
4
-3
| -43% | -$25 |
2016 Q2
5 quarters
|
|
6334
Capricor Therapeutics
CAPR
$455M
| – | – |
-2,400
| Closed | -$20K | – |
|
6335
CBAK Energy Technology Ltd
CBAT
$93.1M
| $0 | ﹤0.01% |
200
-6,100
| -97% | -$8.81K |
2017 Q2
1 quarter
|
|
6336
Comcast Holdings Corp 2.0% Exchangeable Subordinated Debentures due Oct 15 2029
CCZ
| – | – |
-6,456
| Closed | -$323K | – |
|
6337
Cenntro
CENN
$9.11M
| – | – |
0
| – | -$53K |
2017 Q2
1 quarter
|
|
6338
CF Bankshares
CFBK
$220M
| – | – |
-38
| Closed | – | – |
|
6339
51Talk Online Education Group
COE
$73.4M
| – | – |
-377
| Closed | -$24K | – |
|
6340
Teucrium Corn Fund
CORN
$126M
| – | – |
-2,497
| Closed | -$47K | – |
|
6341
Canterbury Park Holding Corp
CPHC
$81.4M
| – | – |
-3
| Closed | – | – |
|
6342
CervoMed
CRVO
$48.7M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
6343
Direxion Daily Healthcare Bull 3X ETF
CURE
$174M
| – | – |
-3,870
| Closed | -$161K | – |
|
6344
CEL-SCI Corp
CVM
$34.1M
| $0 | ﹤0.01% |
4
+1
| +33% | +$63 |
2013 Q4
15 quarters
|
|
6345
Bio Green Med Solution Inc
BGMS
$5.62M
| – | – |
0
| – | – |
2013 Q2
17 quarters
|
|
6346
Dare Bioscience
DARE
$15.2M
| $0 | ﹤0.01% |
7
| – | – |
2015 Q1
10 quarters
|
|
6347
Edesa Biotech
EDSA
$33.8M
| – | – |
0
| – | – |
2017 Q1
2 quarters
|
|
6348
Vaalco Energy
EGY
$632M
| $0 | ﹤0.01% |
200
-52,485
| -100% | -$42.5K |
2013 Q2
17 quarters
|
|
6349
Eledon Pharmaceuticals
ELDN
$202M
| $0 | ﹤0.01% |
2
-4
| -67% | -$332 |
2014 Q3
12 quarters
|
|
6350
Enlivex Ltd
ENLV
$5.06M
| – | – |
-1
| Closed | – | – |
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.